New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
05:58 EDTBAXSBaxano Surgical pullback brings attractive risk/reward, says Brean Capital
Brean Capital believes the recent pullback in shares of Baxano Surgical provides a compelling risk/reward profile relative to its $4 price target. Brean thinks that if Baxano can prove itself over the next two years, it is likely to be taken out. The firm reiterates a Buy rating on the name.
News For BAXS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
07:33 EDTBAXSBrean Capital to hold a summit
Subscribe for More Information
November 13, 2014
17:46 EDTBAXSBaxano Surgical announces termination of Nasdaq listing
Baxano Surgical announced that it is terminating its listing on The Nasdaq Global Market as of the close of business on November 24. The company has previously received notices from Nasdaq that it has failed to maintain a minimum bid price of $1.00 per share. In light of its current financial condition, the company does not anticipate that it will be able to meet such minimums or continue to meet other Nasdaq listing standards in the future. In addition, the company has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in order to facilitate a going concern sale of the company. Following the termination of its listing on Nasdaq, the company intends to terminate its public reporting obligations under the Exchange Act as soon as possible.
12:44 EDTBAXSOn The Fly: Midday Wrap
Subscribe for More Information
09:18 EDTBAXSBaxano Surgical downgraded to Sell from Buy at Summer Street
Subscribe for More Information
07:34 EDTBAXSBaxano Surgical files for voluntary Chapter 11 auction
Subscribe for More Information
November 12, 2014
07:27 EDTBAXSNorth American Spine Society to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use